Reduced stimulation of helper T cells by Ki-ras transformed cells
- PMID: 1826672
- PMCID: PMC1384496
Reduced stimulation of helper T cells by Ki-ras transformed cells
Abstract
A number of viral genes and cellular oncogenes inhibit major histocompatibility complex (MHC) antigen expression at the cell surface. In the case of inhibition of class I MHC antigens by viral genes this results in a reduced recognition by antigen-specific cytotoxic T cells. The activated Ki-ras cellular oncogene carried by the Ki-murine sarcoma virus (Ki-MuSV) in contrast inhibits class II MHC (or Ia) antigen expression on transformed cells. We have studied how transformation with Ki-ras affects recognition by alloreactive helper T cells. We found that the Ki-ras inhibition of class II MHC antigen expression led to greatly reduced stimulation of alloreactive T cells to proliferate and to secrete interferon-gamma (IFN-gamma). These findings support our hypothesis that the ability of an oncogene to reduce class II MHC antigen expression is crucial to its ability to produce tumour cells.
Similar articles
-
Regulation of IFN-gamma-induced host cell MHC antigen expression by Kirsten MSV and MLV. I. Effects on class I antigen expression.Immunology. 1989 May;67(1):21-5. Immunology. 1989. PMID: 2544513 Free PMC article.
-
Major histocompatibility complex antigens in v-Ki-ras transformed cells: the different antigens are expressed and induced by interferons independently of one another and of the anti-viral state.Immunology. 1990 Oct;71(2):224-9. Immunology. 1990. PMID: 1699881 Free PMC article.
-
Effect of cellular density and viral oncogenes on the major histocompatibility complex class I antigen response to gamma-interferon in BALB-c/3T3 cells.Cancer Res. 1990 Feb 1;50(3):601-5. Cancer Res. 1990. PMID: 2105158
-
Turning tumor cells in situ into T-helper cell-stimulating, MHC class II tumor epitope-presenters: immuno-curing and immuno-consolidation.Cancer Treat Rev. 2004 May;30(3):281-90. doi: 10.1016/j.ctrv.2003.08.002. Cancer Treat Rev. 2004. PMID: 15059651 Review.
-
Role of oncogenes in the regulation of MHC antigen expression.Biochem Soc Trans. 1991 Apr;19(2):291-6. doi: 10.1042/bst0190291. Biochem Soc Trans. 1991. PMID: 1716227 Review.
Cited by
-
Precision delivery of RAS-inhibiting siRNA to KRAS driven cancer via peptide-based nanoparticles.Oncotarget. 2019 Jul 30;10(46):4761-4775. doi: 10.18632/oncotarget.27109. eCollection 2019 Jul 30. Oncotarget. 2019. PMID: 31413817 Free PMC article.
-
An immunogenomic stratification of colorectal cancer: Implications for development of targeted immunotherapy.Oncoimmunology. 2015 Apr 2;4(3):e976052. doi: 10.4161/2162402X.2014.976052. eCollection 2015 Mar. Oncoimmunology. 2015. PMID: 25949894 Free PMC article.
-
RAS oncogenes: weaving a tumorigenic web.Nat Rev Cancer. 2011 Oct 13;11(11):761-74. doi: 10.1038/nrc3106. Nat Rev Cancer. 2011. PMID: 21993244 Free PMC article. Review.
-
Modulation of major histocompatibility complex antigen expression by viral infection.Am J Pathol. 1994 Apr;144(4):637-50. Am J Pathol. 1994. PMID: 8160765 Free PMC article. Review. No abstract available.
-
KRAS Mutation and Consensus Molecular Subtypes 2 and 3 Are Independently Associated with Reduced Immune Infiltration and Reactivity in Colorectal Cancer.Clin Cancer Res. 2018 Jan 1;24(1):224-233. doi: 10.1158/1078-0432.CCR-17-1090. Epub 2017 Oct 23. Clin Cancer Res. 2018. PMID: 29061646 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials